Everything we think we know about aging says your immune system slowly falls apart. But a new study published in Cell Reports in August 2026 found something remarkable in people who live past 110: a rare type of killer T cell that appears at four times the levels seen in people in their 70s and 80s and it keeps increasing the older you get.Jamie and Chris break down the University of Osaka's supercentenarian research: what they found, what it actually means, why the science is being careful not to overclaim, and what it might eventually tell us about how to live longer and healthier.What's covered:- Who supercentenarians are and why only about 1 in 1,000 centenarians reach 110- The Cell Reports study: methodology, participants, and what was measured- CD4 cytotoxic T cells: the rare "hybrid" killer cells that shouldn't be this common- The data: ~4% in people aged 70–99, ~9.6% at 100–109, ~17.6% at 110+- Clonal expansion: what it means that a third to half of these cells are near-identical- The cancer surveillance connection: receptor sequences similar to those in cancer patients- What researcher Kosuke Hashimoto said about what this means- Why this might be a marker of longevity rather than a cause of it- The honest limitations: 28 participants, 10 supercentenarians, correlative findings- Inflammaging and why supercentenarians seem to largely avoid it- The bigger picture: genetics, lifestyle, environment, and luck in extreme longevity- Can any of this be replicated or boosted in the general population?New episodes every week. Follow Don't Be An Idiot so you never miss one.